Targeting TYRO3 attenuates apoptotic cell-driven cancer stemness in triple negative breast cancer.
APA
Tran PT, Shim WS, et al. (2026). Targeting TYRO3 attenuates apoptotic cell-driven cancer stemness in triple negative breast cancer.. Cell communication and signaling : CCS. https://doi.org/10.1186/s12964-026-02896-y
MLA
Tran PT, et al.. "Targeting TYRO3 attenuates apoptotic cell-driven cancer stemness in triple negative breast cancer.." Cell communication and signaling : CCS, 2026.
PMID
42026668
같은 제1저자의 인용 많은 논문 (2)
- Re: Andrisha-Jade Inderjeeth, Andrew J Martin, Robert R Zielinski et al. Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304). Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.01.008.
- Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial Insights.